Archives
"Holy Grail" of Anticoagulant Drugs Raises $11 Million in Funding
With the potential to save millions of lives, University of Cambridge's spin-off company XO1 Ltd. raised $11 million in funding to develop what some are calling the holy grail of anticoagulant drugs.
Latest Research Articles
Cow Elk Brave Even Major River Crossings, Study Reveals
Headless RoboCat is Fastest Robot of its Kind [VIDEO]
New York Fights Growing Alligator Problem as Pet Owners Release Them into the Wild
Russian Visionary Reconciles Immortality and Humanity at Global Future 2045 Conference [VIDEO]
Subduction Zone in 'Embryonic' Stage Discovered off Portugal Coast
China Bumps U.S. Out of First Place for Fastest Supercomptuer
Yale Researchers Kill Melanoma Cells Using Virus
Infant Weight Gain During First Month and Head Circumference Linked to IQ Levels
Obese Fathers have Babies with High Body-fat
Sibling Rivalry Could have Serious Effects on Mental Health
Researchers Find Global Cooling as Devastating as Global Warming for Marine Life
Osteoporosis Drug Effective Against Treatment-Resistant Breast Cancer
MOST POPULAR
-
How Airborne Microplastics and Nanoplastics Contribute to Climate Change and Atmospheric Warming
-
Greek Mountain Snow Decline Accelerates as Greece Snow Cover Study 2026 Reveals Climate Change Impact
-
New Study Improves Past Ocean Change Records and Foraminifera Climate Proxy Accuracy
-
How Seals Detox After Foraging Trips and Recover After Deep Dives Using Heart Rate
-
Rare Footage Reveals Dolphins Using Sponges as Tools During Incredible Seafloor Hunting Behavior
